welcome
Medical Xpress - medical research advances and health news

Medical Xpress - medical research advances and health news

Health

Health

Nasal COVID-19 vaccine to enter US clinical trials

Medical Xpress - medical research advances and health news
Summary
Nutrition label

86% Informative

A nasal vaccine for COVID-19 , based on technology developed at Washington University in St. Louis , is poised to enter a phase 1 clinical trial in the U.S. The trial will be conducted by the National Institute of Allergy and Infectious Diseases ( NIAID ), of the National Institutes of Health .

The new trial will evaluate the safety and efficacy of the vaccine administered via two routes: inhaled into the lungs and sprayed into the nose.

VR Score

89

Informative language

91

Neutral language

38

Article tone

formal

Language

English

Language complexity

74

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

Affiliate links

no affiliate links